Therapeutic application of parenteral krill oil
AssigneeStable Solutions LLC
InventorDavid F. Driscoll
Life of this patent
Estimating the term…
Abstract
A method of parenterally administering a composition, the method including parenterally administering to a person a composition including krill oil in an oil-in-water emulsion. A parenterally applicable pharmaceutical composition, including an oil-in-water emulsion including a phospholipid obtained from a marine crustacean.
Claims35
A method of parenterally administering a composition, the method comprising parenterally administering to a person a composition comprising krill oil in an oil-in-water emulsion comprising:
- an n3-FA-containing phospholipid obtained from krill oil, and
- a fish oil containing an n3-FA-containing triglyceride,
- wherein the composition further comprises at least one drug, and wherein a portion of the at least one drug is present in the oil phase of the emulsion and a portion of the same at least one drug in a water-soluble salt is present in the aqueous phase of the emulsion.
A parenterally applicable pharmaceutical composition, comprising an oil-in-water emulsion comprising:
- an n3-FA-containing phospholipid obtained from krill oil, and
- a fish oil containing an n3-FA-containing triglyceride,
- wherein the composition further comprises at least one drug, and wherein a portion of the at least one drug is present in the oil phase of the emulsion and a portion of the same at least one drug in a water-soluble salt is present in the aqueous phase of the emulsion.
A parenterally applicable pharmaceutical composition, consisting essentially of krill oil and fish oil in an oil-in-water emulsion,
- wherein the krill oil contains an n3-FA-containing phospholipid,
- wherein the fish oil containing an n3-FA-containing triglyceride, and
- wherein the composition further consists essentially of at least one drug, and wherein a portion of the at least one drug is present in the oil phase of the emulsion and a portion of the same at least one drug in a water-soluble salt is present in the aqueous phase of the emulsion.
A parenterally applicable pharmaceutical composition, comprising krill oil in an oil-in-water emulsion, wherein the krill oil contains an n3-FA-containing phospholipid, wherein the composition does not contain a vegetable oil,
- wherein the composition further comprises at least one drug, and wherein a portion of the at least one drug is present in the oil phase of the emulsion and a portion of the same at least one drug in a water-soluble salt is present in the aqueous phase of the emulsion.
Dependencies are inferred from the claim text.